Erythropoietin protects PC12 cells from β-amyloid25-35-induced apoptosis via PI3K/Akt signaling pathway

Neuropharmacology

Volumn 56, Issue 6-7, 2009, Pages 1027-1034

  Ma, Rong ^a   Xiong, Nian ^a   Huang, Chengfang ^a   Tang, Qiang ^a   Hu, Benrong ^a   Xiang, Jizhou ^a   Li, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

A ; Akt kinase; Erythropoietin; Glycogen synthase kinase 3 ; Neuroprotection; PC12 cells

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CELL SURVIVAL; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3; NEUROPROTECTIVE AGENTS; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 67349280677     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.02.006     Document Type: Article

References (43)

1. Amaravadi R., and Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest 115 (2005) 2618-2624
2. Anagnostou A., Liu Z., Steiner M., Chin K., Lee E.S., Kessimian N., and Noguchi C.T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. USA 91 (1994) 3974-3978
3. Bao H., Jacobs-Helber S.M., Lawson A.E., Penta K., Wickrema A., and Sawyer S.T. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93 (1999) 3757-3773
4. Bothwell M., and Giniger E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 102 (2000) 271-273
5. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97 (2000) 10526-10531
6. Chen G.J., Xu J., Lahousse S.A., Caggiano N.L., and de la Monte S.M. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J. Alzheimers 5 (2003) 209-228
7. Chong Z.Z., Kang J.Q., and Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab 22 (2002) 503-514
8. Chong Z.Z., Kang J.Q., and Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br. J. Pharmacol 138 (2003) 1107-1118
9. Cohen P., and Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2 (2001) 769-776
10. Dickson D.W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol 56 (1997) 321-339
11. Dolcet X., Soler R.M., Gould T.W., Egea J., Oppenheim R.W., and Comella J.X. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol. Cell Neurosci 18 (2001) 619-631
12. Fisher J.W. Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228 (2003) 1-14
13. Franke T.F., Hornik C.P., Segev L., Shostak G.A., and Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 22 (2003) 8983-8998
14. Grace E.A., Rabiner C.A., and Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114 (2002) 265-273
15. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
16. Hashimoto Y., Niikura T., Chiba T., Tsukamoto E., Kadowaki H., Nishitoh H., Yamagishi Y., Ishizaka M., Yamada M., Nawa M., Terashita K., Aiso S., Ichijo H., and Nishimoto I. The cytoplasmic domain of Alzheimer's amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. J. Pharmacol. Exp. Ther 306 (2003) 889-902
17. Jarvis K., Assis-Nascimento P., Mudd L.M., and Montague J.R. Beta-amyloid toxicity and reversal in embryonic rat septal neurons. Neurosci. Lett. 423 (2007) 184-188
18. Jelkmann W., and Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann. Hematol 83 (2004) 673-686
19. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest 113 (2004) 1535-1549
20. Kawakami M., Sekiguchi M., Sato K., Kozaki S., and Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276 (2001) 39469-39475
21. Kaytor M.D., and Orr H.T. The GSK3 beta signaling cascade and neurodegenerative disease. Curr. Opin. Neurobiol 12 (2002) 275-278
22. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., and Akaike A. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J. Biol. Chem. 276 (2001) 13541-13546
23. Lasne F., and de Ceaurriz J. Recombinant erythropoietin in urine. Nature 405 (2000) 635
24. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., Savino C., Bianchi M., Nielsen J., Gerwien J., Kallunki P., Larsen A.K., Helboe L., Christensen S., Pedersen L.O., Nielsen M., Torup L., Sager T., Sfacteria A., Erbayraktar S., Erbayraktar Z., Gokmen N., Yilmaz O., Cerami-Hand C., Xie Q.W., Coleman T., Cerami A., and Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
25. Li F., Chong Z.Z., and Maiese K. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13 (2004) 265-289
26. Li G., Ma R., Huang C., Tang Q., Fu Q., Liu H., Hu B., and Xiang J. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci. Lett. 442 (2008) 143-147
27. Maiese K., Li F., and Chong Z.Z. New avenues of exploration for erythropoietin. JAMA 293 (2005) 90-95
28. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas Jr. F., Tabira T., and Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 268 (1993) 11208-11216
29. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., and Tohyama M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem 73 (1999) 2037-2046
30. Mcphie D.L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K.J., Manly S.P., Kozlowski M.R., Neve K.A., and Neve R.L. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci 23 (2003) 6914-6927
31. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
32. Nakata S., Matsumura I., Tanaka H., Ezoe S., Satoh Y., Ishikawa J., Era T., and Kanakura Y. NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J. Biol. Chem. 279 (2004) 55578-55586
33. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., and Cowburn R.F. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol 58 (1999) 1010-1019
34. Quelle F.W., Wang D., Nosaka T., Thierfelder W.E., Stravopodis D., Weinstein Y., and Ihle J.N. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell Biol. 16 (1996) 1622-1631
35. Ryder J., Su Y., and Ni B. Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations. Cell Signal 16 (2004) 187-200
36. Signore A.P., Weng Z., Hastings T., Van Laar A.D., Liang Q., Lee Y.J., and Chen J. Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J. Neurochem 96 (2006) 428-443
37. Takada Y., Yonezawa A., Kume T., Katsuki H., Kaneko S., Sugimoto H., and Akaike A. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmacol. Exp. Ther 306 (2003) 772-777
38. Takada-Takatori Y., Kume T., Sugimoto M., Katsuki H., Sugimoto H., and Akaike A. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51 (2006) 474-486
39. Wu Y., Shang Y., Sun S.G., Liu R.G., and Yang W.Q. Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells. Neurosci. Bull. 23 (2007) 156-164
40. Yu X., Shacka J.J., Eells J.B., Suarez-Quian C., Przygodzki R.M., Beleslin-Cokic B., Lin C.S., Nikodem V.M., Hempstead B., Flanders K.C., Costantini F., and Noguchi C.T. Erythropoietin receptor signalling is required for normal brain development. Development 129 (2002) 505-516
41. Zhang F., Signore A.P., Zhou Z., Wang S., Cao G., and Chen J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J. Neurosci. Res. 83 (2006) 1241-1251
42. Zhao W., Kitidis C., Fleming M.D., Lodish H.F., and Ghaffari S. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood 107 (2006) 907-915
43. Zheng W.H., Bastianetto S., Mennicken F., Ma W., and Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115 (2002) 201-211